Sequencing the genome is a great way to get information about genetic diseases, predispositions to diseases, forms and prognosis of treatment. Determination of the nucleotide sequence of DNA and its subsequent interpretation will give you more information than all possible analyzes to date.
The results of sequencing are the most detailed instruction for doctors on the treatment of a particular patient, as well as the possibility to raise the direction of diagnosis to unprecedented peaks.
You will ask, why then did not we, or our friends, have made a decoding of our own DNA? Because the complete sequencing of the genome of one person is very expensive procedure, at a cost comparable with the purchase of a used car. And ten years ago, with money spent on deciphering the genome, you could buy a plane.
Proceeding from what has been said, one can see a tendency to cheaper this service.
The Shivom project provides a comprehensive solution for genome sequencing for patients and medical and pharmacological institutions, individuals and organizations.
The development of the Shivom project using the blockchain technology gives each owner (donor) an additional and unrivaled opportunity for safely storing information about his genome, while also earning on the sale of his data to pharmacological and medical companies, research organizations, patient support groups and insurance companies for analysts.
The blockchain technology contributes to the creation of a genomic ecosystem. Thanks to the blockchain, users can be sure that the data belongs to the data owners themselves. It provides a transparent and secure source of information for organizations interested in using this data.
Sequencing the genome has many advantages:
• Determination of the best course of treatment in relation to this situation.
• Prevention of diseases in healthy people.
• Diagnosis of disease risks.
• Diagnosis of diseases.
• Treatment, including selection of the most effective drug and dosage.
• Prognosis of the course of the disease.
• Identification of new targets.
Advantages of the Shivom platform:
• Donors receive a decoded gene located in the blockchain.
• Patients receive individual information about health, well-being and lifestyle.
• Donors gain access to their unit by selling access directly to third parties, such as pharmaceutical companies.
• Pharmaceutical companies use the Shivom platform to improve the development of medicines, medical companies use these data for diagnostic and therapeutic purposes, insurance companies use insurance for life insurance.
• Shivom users have full and small-scale control over who can access data, even after the 3rd person has access to the data.
Token OmiX
The internal currency on the Shivom platform will be the OmiX token.
Advantages of the OmiX token:
• getting quality services in the Shivom ecosystem;
• purchase of a set for genome sequencing;
• sponsorship of sequencing projects;
• getting apps for health / fitness from third-party suppliers;
• access to the genome database;
• payment for donated data / for participation in research.
Selling tokens
In order to develop the Shivom project, the sale of tokens is carried out. Now the pre-sale is open (bonus 3%), which will last until April 27, 2018.
Public sale of OmiX tokens starts on May 3 and ends on May 9, 2018, if the tokens are not sold earlier.
3 billion tokens OmiX are issued.
990 million tokens OmiX are offered for sale.
The cost of 1 OmiX = 0.0775 USD.
Hard cap: 35 million US dollars.
Accepted for payment: ETH, BTC, USD.
The Shivom project will be of interest to those who care about their health and their loved ones, as well as medical workers, pharmaceutical workers, insurance companies. Also it will be interesting to the cryptoinvestors wishing to successfully diversify their portfolio.
More detailed information about the project Shivom, the development team, the terms of purchase of the tokens you can find on the official sites of the project:
Website
Ann Thread
Whitepaper
Facebook
Twitter
Telegram
Reddit
Medium
YouTube
Author: happy weblancer